Zurcher Kantonalbank Zurich Cantonalbank Purchases Shares of 2,465 NanoString Technologies Inc (NASDAQ:NSTG)

Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in shares of NanoString Technologies Inc (NASDAQ:NSTG) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 2,465 shares of the biotechnology company’s stock, valued at approximately $75,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in NSTG. James Investment Research Inc. purchased a new stake in shares of NanoString Technologies in the 2nd quarter worth about $25,000. Truvestments Capital LLC purchased a new stake in shares of NanoString Technologies in the 2nd quarter worth about $74,000. Pearl River Capital LLC purchased a new stake in shares of NanoString Technologies in the 1st quarter worth about $76,000. First Mercantile Trust Co. purchased a new stake in shares of NanoString Technologies in the 1st quarter worth about $122,000. Finally, BNP Paribas Arbitrage SA lifted its position in shares of NanoString Technologies by 67,950.0% in the 1st quarter. BNP Paribas Arbitrage SA now owns 5,444 shares of the biotechnology company’s stock worth $130,000 after purchasing an additional 5,436 shares during the period.

Shares of NanoString Technologies stock traded down $1.62 during trading on Thursday, hitting $25.39. The company’s stock had a trading volume of 12,940 shares, compared to its average volume of 568,460. The company has a debt-to-equity ratio of 1.27, a quick ratio of 4.76 and a current ratio of 5.21. The company has a fifty day simple moving average of $28.94 and a two-hundred day simple moving average of $26.65. The company has a market capitalization of $1.00 billion, a PE ratio of -9.04 and a beta of 1.08. NanoString Technologies Inc has a 52 week low of $13.26 and a 52 week high of $34.78.

NanoString Technologies (NASDAQ:NSTG) last issued its quarterly earnings results on Wednesday, July 31st. The biotechnology company reported ($0.57) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.55) by ($0.02). The business had revenue of $30.35 million during the quarter, compared to the consensus estimate of $29.00 million. NanoString Technologies had a negative return on equity of 118.03% and a negative net margin of 68.16%. As a group, analysts predict that NanoString Technologies Inc will post -2.35 EPS for the current year.

Several equities research analysts have recently commented on NSTG shares. BidaskClub cut shares of NanoString Technologies from a “buy” rating to a “hold” rating in a research report on Tuesday, August 6th. Zacks Investment Research raised shares of NanoString Technologies from a “sell” rating to a “hold” rating in a research report on Friday, August 16th. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. NanoString Technologies currently has a consensus rating of “Buy” and an average price target of $24.60.

In related news, SVP David W. Ghesquiere sold 18,421 shares of the stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $28.23, for a total value of $520,024.83. Following the completion of the transaction, the senior vice president now directly owns 52,572 shares in the company, valued at approximately $1,484,107.56. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP David W. Ghesquiere sold 6,954 shares of the stock in a transaction dated Wednesday, June 5th. The stock was sold at an average price of $29.41, for a total transaction of $204,517.14. Following the completion of the transaction, the senior vice president now owns 44,868 shares of the company’s stock, valued at $1,319,567.88. The disclosure for this sale can be found here. Over the last quarter, insiders sold 166,333 shares of company stock valued at $4,565,924. 5.10% of the stock is owned by company insiders.

About NanoString Technologies

NanoString Technologies, Inc provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files.

Further Reading: What is a Reverse Stock Split?

Institutional Ownership by Quarter for NanoString Technologies (NASDAQ:NSTG)

Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.